I posted on the original story about the FDA panel recommending approval a few weeks ago. In that post, I mentioned that Icahn school of medicine holds the patent on the racemic ketamine (instead of S-ketamine) intranasal formulation for treatment of depression.

I heard about the approval on NPR, where they interviewed a doctor from Icahn school of medicine to talk about the benefits of such a formulation, without any mention of this patent. Is there any way to find out if J&J licensed their patent?

Edit: meant racemic instead of non racemic